News
-
-
-
COMMUNIQUÉ DE PRESSE
Vanta to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET
Vanta to present at Maxim Group's 'Health, Wellness & Longevity' Virtual Conference showcasing its U.S.-focused consumer health sciences strategy for peptide therapies, nutraceuticals & functional hydration products -
-
-
COMMUNIQUÉ DE PRESSE
Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Vanta Holdings Inc. announces proposed non-brokered private placement financing of up to $2.5M to advance its longevity and consumer health sciences platform. Insiders may participate. Closing expected around June 30, 2026 -
-
-
COMMUNIQUÉ DE PRESSE
Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform
Vanta Holdings Inc. announces strategic operating and infrastructure agreement for a U.S. peptide therapy platform leveraging telehealth-enabled commercialization. Focus on wellness and healthspan extension initiatives -
